Test directory: Paraneoplastic Autoantibody Eval

Ordering Code 5620
Test Name Paraneoplastic Autoantibody Eval
Alias Paraneoplastic Autoantibody Evaluation
Acetylcholine Receptor (Muscle AChR) Antibodies
ANNA (Antineuronal Nuclear Antibody)
Preferred Specimen Serum
Preferred Container SST (Gold)
Optimum Volume 5 mL
Collection Instructions Specimen collection is recommended prior to initiation of immunosuppressant medication or intravenous immunoglobulin (IVIg) treatment. Patient should have no general anesthetic or muscle-relaxant drugs in the previous 24 hours
Radioisotopes, therapeutic or diagnostic, have the potential for assay interference.
Handling Instructions Ensure that 2 aliquots are sent for testing.
Transport Requirements Oahu: Refrigerated
Airline: Refrigerated
Specimen Stability Ambient: 3 Days
Refrigerated: 28 Days
Frozen: 28 Days
Rejection Criteria Grossly hemolyzed, Grossly Lipemic, Grossly Icteric
Avail. Stat NO
Analytic Time Up to 17 Days
Methodology IFA:
Amphiphysin Ab, S;
Anti-Glial Nuclear Ab, Type 1;
Anti-Neuronal Nuclear Ab, Type 1;
Anti-Neuronal Nuclear Ab, Type 2;
Anti-Neuronal Nuclear Ab, Type 3;
CRMP-5-IgG, S;
Purkinje Cell Cytoplasmic Ab Type 1;
Purkinje Cell Cytoplasmic Ab Type 2;
Purkinje Cell Cytoplasmic Ab Type Tr
RIA:
Neuronal (V-G) K+ Channel Ab, S;
P/Q-Type Calcium Channel Ab
Reference Lab  Mayo Medical Lab

Reference range(s)

The reference ranges listed below are valid on this date of July 3, 2025.
Component Age Male Norm Male Critical Low Male Critical High Female Norm Female Critical High Female Critical Low Units Add'l info
AGNA-1, S ALL See report.
Amphiphysin Ab, S ALL See report.
ANNA-1, S ALL See report.
ANNA-2, S ALL See report.
ANNA-3, S ALL See report.
P/Q-Type Calcium Channel Ab ALL <=0.02 <=0.02 nmol/L
CRMP-5-IgG, S ALL See report.
PCA-2, S ALL See report.
PCA-1, S ALL See report.
PCA-Tr, S ALL See report.
Neuronal (V-G) K+ Channel Ab, S ALL <=0.02 <=0.02 nmol/L
IFA Notes ALL See report.